[ad_1]
Yesterday, Elixinol Global (ASX: EXL) (OTC: ELLXF) called for a halt to the negotiations as part of a capital increase, in the hope that this judgment could last until June 5th. Tonight, the company announced it had raised $ 50 million by selling $ 3.90 worth of shares in a deal led by Bell Potter Securities.
I recognize the strong support of new and existing institutional investors for accelerating the development of the company in the United States and around the world. We are witnessing an unprecedented positive change in consumer appetite for CBD and hemp products.
Paul Benhaim, CEO of Elixinol Global
Elixinol plans to double its current production capacity in the United States. In addition, by securing additional raw materials, the Company will be well positioned to accelerate the growth of Elixinol brand CBD products and strategic opportunities.
This is the third and largest capital increase of the company, which has finalized its IPO at the end of 2017 at A $ 1.00 and raising A $ 20 million. In September, he raised 40 million Australian dollars and sold shares at 1.85 Australian dollar. Shares reached A $ 5.93 in April.
Take Advance by signing up for 420 Investor, the most comprehensive and comprehensive premium subscription service for cannabis traders and investors since 2013.
[ad_2]
Source link